Antapodia Therapeutics, Inc. was founded by Dr. Patrick Y. Yang, who was formerly Executive Vice President and global head of Roche Pharmaceuticals, EVP of Technical Operations of Genentech, Vice President of Merck, and EVP at Juno Therapeutics, Inc. (now part of BMS). Dr. Yang is currently Co-founder/Executive Vice Chairman, National Resilience, Inc. and is serving on the Board of Directors of Codexis, Inc.,  Amyris, Inc., PharmaEssentia Corp., Sana Biotechnologies, inc., Acepodia, Inc., AltruBio, Inc. and Antheia, Inc. The company's Scientific Advisory Board includes leading experts in cancer metastasis, invadopodia, and nanotherapy from the University of Toronto, UCSF, Harvard Medical School, and Israel's Technion.

Patrick Y. Yang, Ph.D.

Patrick Y. Yang, Ph.D. (yang_pat@yahoo.com)

Formerly EVP of Technical Operations, Genentech/Roche
EVP, Juno Therapeutics, Inc.
Co-founder/Executive Vice Chairman, National Resilience, Inc.
Board of Directors, Codexis, Inc.,Amyris, Inc., PharmaEssentia Corp., Sana Biotechnologies, Acepodia, Inc., AltruBio, Inc., and Antheia, Inc.

Kelvin K. Tsai, M.D., Ph.D.

Kelvin Tsai, M.D., Ph.D. (kelvin.tsai@antapodia.com)

Scientific Co-Founder/Director (invadopodia, cancer metastasis)
Ph.D. in Biological Sciences - Genetics & Complex Diseases, Harvard University, MA, USA
M.D., Taipei Medical University, Taipei, Taiwan
Research Scientist, University of Pennsylvania, PA, USA
Research Scientist, University of California - San Francisco, CA, USA
Associate Investigator/Attending Physician, National Institute of Cancer Research, National Health Research Institutes, Taiwan

Yuval Shaked, Ph.D.

Yuval Shaked, Ph.D. (yshaked@technion.ac.il)

Scientific Advisor/Director (cancer metastasis; nanotherapy)
Director, Technion Integrated Cancer Center; Professor, Department of Cell
Biology and Cancer Science, Rappaport Faculty of Medicine; Technion – Israel Institute of Technology, Haifa, Israel

Yuval Shaked, Ph.D.

Valerie M. Weaver, Ph.D. (valerie.weaver@ucsfmedctr.org)

Scientific Advisor (cancer metastasis)
Director, Center for Bioengineering and Tissue Regeneration
Professor, Departments of Surgery & Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF)

Robert S. Kerbel, Ph.D.

Robert S. Kerbel, Ph.D. (robert.kerbel@sri.utoronto.ca)

Chair, Scientific Advisory Board (cancer metastasis, experimental therapeutics)
Professor, Department of Medical Biophysics, University of Toronto
Senior Scientist, Sunnybrook Research Inst., Sunnybrook Health Sciences Center, Toronto, Canada

Kevin Struhl, Ph.D.

Kevin Struhl, Ph.D. (kevin@hms.harvard.edu)

Scientific Advisor (cancer gene regulation)
David Wesley Gaiser Professor, Biological Chemistry and Molecular
Harvard Medical School
Elected Member of National Academy of Sciences, USA
Elected Member of National Academy of Medicine, USA


Hon Leong, M.Sc., Ph.D. (hon.leong@sri.utoronto.ca)

Scientific Advisor (invadopodia, anti-metastasis therapy)
Associate Professor, Department of Medical Biophysics, University of Toronto
Scientist, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada


Designed by Justin V. Tsai in 2021

Copyright © Antapodia Therapeutics, Inc., WA, USA. All Rights Reserved.